Form 4: Fulgent Genetics COO Reports Stock Transaction
Insider Transaction (Form 4)
Jian Xie, President and COO of Fulgent Genetics, Inc., reported a transaction in 4,361 shares of common stock on July 26, 2026.
Summary
- Tax/exercise-price withholding: disposed of 4,361 Common Stock at $19.67 ($85,781) on July 26, 2026; holds 363,244 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jian Xie — Officer (President and COO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-26 | Tax/exercise-price withholding | Common Stock | 4,361 | $20 | $85.8K | 363,244 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-26 | Tax/exercise-price withholding (4,361 shares) |
Keywords
insider transaction, Form 4, FLGT, Fulgent Genetics, Inc., neutral, Jian Xie
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.